- ►annals.org [PDF] TH Jafar, PC Stark, CH Schmid, M Landa, G … - Annals of internal medicine, 2003 - Am Coll Physicians Background: Angiotensin-converting enzyme (ACE) inhibitors reduce blood pressure
and urine protein excretion and slow the progression of chronic kidney disease.
Purpose: To determine the levels of blood pressure and urine protein ... Cited by 287 - Related articles - BL Direct - All 5 versions
- ►utsouthwestern.edu [PDF] JT Wright Jr, G Bakris, T Greene, LY Agodoa, … - Jama, 2002 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 522 - Related articles - BL Direct - All 11 versions
- ►annals.org [PDF] MJ Sarnak, T Greene, X Wang, G Beck, JW … - Annals of internal medicine, 2005 - Am Coll Physicians Background: Hypertension is a risk factor for progression of chronic kidney
disease. The optimal blood pressure to slow pro- gression is unknown. Objective:
To evaluate the effects of a low target blood pressure on kidney failure ... Cited by 135 - Related articles - All 11 versions
TH Jafar, PC Stark, CH Schmid, S … - Kidney international, 2005 - nature.com We analyzed a database of 11 randomized controlled trials including 1860
patients with nondiabetic kidney disease. We compared randomized groups for the
decline in urine protein excretion and kidney disease progression (combined ... Cited by 26 - Related articles - All 5 versions
TH Jafar, CH Schmid, PC Stark, R Toto, G … - Nephrology Dialysis Transplantation, 2003 - ERA-EDTA Methods. We analysed a pooled database of patients with non-diabetic renal
disease enrolled in 11 randomized controlled trials evaluating the efficacy of
angiotensin-converting enzyme inhibitors (ACEIs) for slowing renal disease ... Cited by 28 - Related articles - BL Direct - All 6 versions
N Nakao, A Yoshimura, H Morita, M Takada, T … - ACC Current Journal Review, 2003 - Elsevier Results: The mean age was 45 years, 47% were male, mean BP 130/75 mm Hg, 65% had
glomerular disease, 18% hypertension, and there was no between group difference
in ACE gene polymorphism. The mean serum creatinine was 2.9 mg/mL, 22% had ... Cited by 875 - Related articles - BL Direct - All 25 versions
TH Jafar, PC Stark, CH Schmid, M Landa, G … - Kidney international, 2001 - nature.com 1 Other members of the Angiotensin-Converting Enzyme Inhibition and Progression
of Renal Disease (AIPRD) Study Group include: R. Toto (Dallas, TX, USA), BM
Brenner (Boston, MA, USA), A. Kamper (Copenhagen, Denmark), P. Zucchelli ( ... Cited by 200 - Related articles - BL Direct - All 3 versions
T Terajima, MS Pharm, S Yamagata, N Satoh, … - Unpublished data provided by study investigators - formkit.com INTRODUCTION According to a report of the Japanese Society for Dialysis Therapy
published in 2001,1 more than 209,000 patients in Japan were receiving
long-term, chronic dialysis; this number has been increasing steadily at a ... Related articles - View as HTML - BL Direct - All 6 versions
P Ruggenenti, A Perna, G Loriga, M Ganeva, B … - The Lancet, 2005 - Elsevier We undertook a multicentre, randomised controlled trial of patients with
non-diabetic proteinuric nephropathies receiving background treatment with the
ACE inhibitor ramipril (2·5–5 mg/day). We randomly assigned participants ... Cited by 100 - Related articles - All 8 versions
- ►annals.org [PDF] TH Jafar, CH Schmid, M Landa, I Giatras, R … - Annals of internal medicine, 2001 - Am Coll Physicians Tazeen H. Jafar, MD, MPH; Christopher H. Schmid, PhD; Marcia Landa, MA; Ioannis
Giatras, MD; Robert Toto, MD; Giuseppe Remuzzi, MD; Giuseppe Maschio, MD; Barry
M. Brenner, MD; Annelise Kamper, MD; Pietro Zucchelli, MD; Gavin Becker, ... Cited by 529 - Related articles - BL Direct - All 4 versions
